FY2021
Equity funding supported development
Statutory financing cash inflow was A$17.3 million, including A$18.1 million proceeds from securities issues, while the Group remained without production or sales.
ASX: HFR · Five-year financial review
(ASX: HFR) Highfield Resources Limited Financial Review - FY2021~25
Highfield Resources remained a development-stage potash group through FY2025. Its five-year record is most usefully read through Group liquidity, statutory cash-flow lanes, capitalised exploration and evaluation balances, and financing structure—not a production or sales trend.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
FY2025 closing cash
A$3.474m
Statutory year-end cash and cash equivalents.
FY2025 operating cash outflow
A$8.617m
Statutory operating cash-flow subtotal.
FY2025 total liabilities
A$75.843m
Consolidated current and non-current liabilities.
FY2025 convertible notes
A$51.324m
Current carrying amount, not a cash-flow measure.
Five years in context
Highfield’s annual records identify the Group as being in exploration and development rather than production. In FY2021 the auditor described no production or sales; the FY2025 report says interest on cash holdings was revenue while the Group remained in the exploration phase.
Annual accounting policies establish Australian dollars as the Group presentation currency, with the Spanish subsidiary using euros as functional currency. A FY2024 extraction tag conflicts with that context, but the FY2025 packet reports matching FY2024 comparative balances in AUD. The displayed Group series is therefore A$ reported amounts, with no currency translation.
Events behind the numbers
FY2022
Senior-facility framework
The Group signed principal credit facilities for up to €320.6 million, with drawdown dependent on closing the equity gap; short-term bank debt at year end was A$11.3 million.
FY2023
Convertible-note funding
Financing cash inflow was A$14.3 million. The company described approximately A$25 million of EMR/Tectonic convertible notes and a further US$6 million investment on similar terms.
FY2024
Placement and funding uncertainty
Statutory financing cash inflow was A$11.5 million; the report also identified a material uncertainty over going concern dependent on further funds to progress Muga.
FY2025
Facility termination and impairment
The senior project-finance facility was terminated. The Group wrote off related capitalised transaction costs, with the disclosed A$45.1 million impairment contributing to the FY2025 loss.
FINANCIAL REVIEW / 01
Financial position: capitalised project assets and rising liabilities
Total assets increased from A$141.5 million in FY2021 to A$221.1 million in FY2024, alongside the capitalised exploration-and-evaluation balance. Total liabilities rose from A$3.0 million to A$75.8 million, while net assets were A$145.3 million at FY2024. The FY2025 issuer disclosure reports net assets of A$91.9 million at rounded precision, but the frozen packet does not supply a complete structured Group total-assets cell, so the report does not derive one.
At FY2025, total current liabilities were A$75.6 million, including A$51.3 million of convertible-note carrying amount; total liabilities were A$75.8 million. Short-term bank debt was nil, versus A$7.5 million in the comparative. These balances describe liquidity structure, not a repayment or fundraising forecast.
Consolidated total assets and liabilities — FY2021-FY2024
A$ million
Total assetsTotal liabilities
AI-generated presentation · values from Consolidated financial position — FY2021-FY2024; no missing values plotted as zero.
Consolidated financial position — FY2021-FY2024
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Total assets | 141.5 | 168.0 | 203.9 | 221.1 |
| Total liabilities | 3.0 | 20.2 | 60.6 | 75.8 |
| Net assets / total equity | 138.5 | 147.7 | 143.3 | 145.3 |
A$ million; consolidated Group rows only, not parent-entity disclosures.
FY2024 source-row metadata carries a USD tag, but FY2025 gives matching FY2024 liability comparatives in AUD and FY2021-FY2023 policies state AUD presentation. This is retained as an extraction-metadata conflict, not an FX conversion.
FY2025 total-assets and total-equity rows are not structured in the frozen packet and are not imputed.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 liquidity and financing balances
A$ million
| Metric | FY2025 |
|---|---|
| Cash and cash equivalents | 3.5 |
| Total current liabilities | 75.6 |
| Total liabilities | 75.8 |
| Net assets (issuer-reported rounded) | 91.9 |
| Convertible-note current carrying amount | 51.3 |
| Deferred exploration and evaluation closing balance | 148.1 |
A$ million; all rows are consolidated statutory FY2025 balances.
Convertible notes comprise host debt and embedded conversion-option derivative; the carrying amount is not FY2025 financing cash received.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 02
Loss remained driven by corporate and financing costs
Loss before tax was A$6.7 million in FY2021, A$5.8 million in FY2022, A$12.1 million in FY2023, A$19.2 million in FY2024 and A$69.8 million in FY2025. The FY2025 outcome includes a disclosed A$45.1 million write-off of capitalised Muga financing transaction costs following facility termination; it is not operating cash consumption.
Professional and consultants’ fees were materially above FY2021-FY2022 levels in FY2023-FY2025, peaking in FY2024 before easing in FY2025. The FY2025 report attributes higher legal costs to the new convertible-note agreement and Spanish corporate matters relating to Geoalcali. Employee and director costs remain separate from project capitalisation and financing cash flows.
Loss before income tax
A$ million
Loss before income tax
AI-generated presentation · values from Group loss and selected expense drivers; no missing values plotted as zero.
Group loss and selected expense drivers
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss before income tax | (6.7) | (5.8) | (12.1) | (19.2) | (69.8) |
| Professional and consultants’ fees | (1.0) | (0.9) | (1.9) | (4.7) | (4.0) |
| Director and employee costs | (3.3) | (2.4) | (3.3) | (3.5) | (3.2) |
A$ million. Parent-entity disclosures and cash-flow reconciliation add-backs are excluded.
Expense signs are preserved from consolidated profit-or-loss rows. FY2025 loss includes impairment charges and is not a cash-flow measure.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 03
Cash-flow lanes show financing did not offset Group cash use
Operating cash outflow was reported in every year and rose to A$9.9 million in FY2023 before easing to A$8.6 million in FY2025. Net investing outflows persisted, but are not identical to exploration-and-evaluation payments because the statutory investing subtotal includes other investing movements. Financing inflows were positive in every displayed year yet were smaller than aggregate FY2025 operating and investing outflows.
FY2025 financing cash inflow of A$2.7 million reflected the conditional institutional-placement component and convertible-note proceeds, partly offset by project-finance commitment fees. It is distinct from the A$51.3 million closing convertible-note liability.
Statutory cash-flow lanes
A$ million
Net cash used in operating activitiesNet cash used in investing activitiesNet cash provided by financing activities
AI-generated presentation · values from Consolidated cash-flow lanes; no missing values plotted as zero.
Closing cash at each 31 December
A$ million
Cash and cash equivalents at year end
AI-generated presentation · values from Consolidated cash-flow lanes; no missing values plotted as zero.
Consolidated cash-flow lanes
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash used in operating activities | (4.3) | (4.0) | (9.9) | (8.8) | (8.6) |
| Net cash used in investing activities | (10.7) | (12.1) | (9.6) | (5.3) | (2.9) |
| Net cash provided by financing activities | 17.3 | 13.5 | 14.3 | 11.5 | 2.7 |
| Cash and cash equivalents at year end | 22.2 | 19.4 | 14.1 | 12.0 | 3.5 |
A$ million. Negative values are reported cash outflows; financing is a separate statutory subtotal.
Net investing cash flow is not substituted with exploration-and-evaluation payments: it can include other investing receipts and outlays.
FY2024 selected rows carry the same currency-metadata conflict; FY2025 rows and comparatives are explicitly AUD.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 04
Muga carrying value, funding arrangements and 2025 legal hold
The deferred exploration-and-evaluation closing balance rose from A$118.4 million in FY2021 to A$155.1 million in FY2024, then was A$148.1 million at FY2025. These are accounting carrying amounts at cost, not project NPV, construction budget or annual cash expenditure. A FY2025 profit-or-loss row labels A$1.6 million as impairment–exploration, while the complete issuer explanation says the expense related to unused mining equipment and that Goyo was not an E&E impairment trigger. The report therefore does not describe that expense as an E&E carrying-value write-off.
The FY2022 senior financing facilities were conditional on funding the equity gap; in FY2025 the senior facility was terminated. Muga was placed on hold pending legal clarity on the Goyo concession matter. Expected project-contract payments not recognised as liabilities are not added to the balance-sheet or cash-flow tables.
Deferred exploration and evaluation closing carrying balance
A$ million
Closing balance
AI-generated presentation · values from Deferred exploration and evaluation expenditure — closing carrying balance; no missing values plotted as zero.
Deferred exploration and evaluation expenditure — closing carrying balance
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Closing balance | 118.4 | 126.6 | 147.3 | 155.1 | 148.1 |
A$ million at cost; this is a closing carrying balance, not annual project spending, a valuation or a funding requirement.
FY2021 statement row is explicitly AUD; FY2021-FY2023 policies state Group AUD presentation; FY2025 gives FY2024’s matching balance as an AUD comparative. Some extracted schedule metadata says USD. No FX conversion was made and the conflict is retained for review.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Reading the figures
- FY2024 source-row currency metadata conflicts with AUD Group presentation evidence and FY2025 AUD comparative values. The report uses reconciled A$ reported values without FX conversion; the conflict remains in the coverage review.
- The FY2025 issuer claim reports rounded Group net assets, but the packet lacks a complete structured Group total-assets cell. The report displays the reported net-assets claim at its stated precision and does not derive total assets.
- The FY2025 P&L label for impairment–exploration conflicts with the complete issuer explanation that attributes the expense to unused mining equipment and says Goyo is not an E&E impairment trigger; the report retains that semantic boundary.
- The report does not infer production, sales, project completion, valuation, future funding availability or debt repayment outcomes.
- Expected Muga contract payments not recognised as liabilities are not added to reported debt, liabilities or cash-flow measures.
- Prepared from existing year-by-year extraction records only. No raw-source retrieval, database query, financial web research or MiniMax call. GPT review against saved extractions; not an independent original-document audit.
Annual-report source registry
- Highfield Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Highfield Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Highfield Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Highfield Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Highfield Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.